Video Experimental Relacionado
Updated: Feb 14, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.5K
Leucemia linfocítica crónica
Michael Hallek1, Tait D Shanafelt2, Barbara Eichhorst1
1Department of Internal Medicine, Center of Integrated Oncology Köln Bonn, University Hospital of Cologne, Cologne, Germany.
Lancet (London, England)
|February 26, 2018
Resumen
Los avances recientes en la patogénesis de la leucemia linfocítica crónica (LLC) han producido nuevas herramientas de pronóstico y terapias dirigidas, mejorando los resultados de los pacientes. Esta revisión cubre el progreso y analiza las estrategias óptimas de manejo de la enfermedad.
Área de la Ciencia:
- Hematología
- En el campo de la oncología
- Medicina Clínica
Sus antecedentes:
- La leucemia linfocítica crónica (LLC) es la leucemia más prevalente en las naciones desarrolladas, generalmente diagnosticada a los 72 años.
- Las decisiones de tratamiento para la leucemia linfocítica crónica se guían por los sistemas de estadificación Rai y Binet y la presencia de síntomas.
- La quimioterapia y los anticuerpos monoclonales anti-CD20 representan el estándar de atención para muchos pacientes con CLL.
Objetivo del estudio:
- Revisar los avances recientes en el manejo de la LLC.
- Para resaltar nuevas herramientas de pronóstico y terapias dirigidas.
- Identificar las cuestiones emergentes en el manejo óptimo de la enfermedad de CLL.
Principales métodos:
- Revisión de la literatura científica reciente sobre la leucemia linfocítica crónica.
- Análisis de nuevas herramientas de pronóstico y terapias dirigidas.
- Discusión de las estrategias de tratamiento actuales y futuras.
Principales resultados:
- Avances significativos en la comprensión de la patogénesis de la CLL.
- Desarrollo de nuevas herramientas de pronóstico y terapias dirigidas (ibrutinib, idelalisib, venetoclax).
- Mejora de los resultados clínicos para subgrupos específicos de pacientes con LLC.
Conclusiones:
- Las terapias dirigidas han alterado el estándar de atención para ciertos pacientes con LLC.
- La investigación en curso es crucial para refinar el manejo óptimo de la enfermedad.
- Se necesitan más investigaciones para abordar nuevas cuestiones en el tratamiento de la LLC.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:23Chronic Pharyngitis
12.5K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.5K
01:24Chronic Pancreatitis I: Introduction
750
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
750
01:25Chronic Kidney Disease I: Introduction
768
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
768
01:17Chronic Bowel Disorders: Introduction
816
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
816
01:29Chronic Pancreatitis II: Collaborative Care
383
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
383
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K